Europe Spinal Cord Stimulation Devices Market (2019-2025)

Europe Spinal Cord Stimulation Devices Market (2019-2025)

  • September 2019 •
  • 72 pages •
  • Report ID: 5823313 •
  • Format: PDF
The Europe Spinal Cord Stimulation Devices Market would witness market growth of 7.6% CAGR during the forecast period (2019-2025). Stimulation of the spinal cord is most helpful for nerve injury, leading to severe forms of chronic pain. Spinal cord stimulation is a relatively new technique that can help manage chronic distress when it is not possible to remove the cause or repair the injury. The device comprises a wire or "electrode" that is stimulating or is linked to the control unit or "generator." The widespread use of spinal cord stimulation systems for chronic pains is expected to strengthen the market scenario over the forecast period

Spinal cord stimulation systems are available in different forms. The devices that are used most often are implanted fully and have a pulse generator that acts as a battery. The novel devices feature rechargeable pulse generator systems that are charged through the skin. Apart from these types, other pulse generators do not require any charging and are implanted completely; however, their battery life is relatively shorter. Another system includes a transmitter, a receiver, and an antenna that depends on the radio frequency that powers the device. While the receiver is implanted in the body, these systems carry the antenna and transmitters outside the body.

Based on Product, the market is segmented into Rechargeable and Non-Rechargeable. Based on Application, the market is segmented into Complex Regional Pain Syndrome, Unsuccessful Disk Surgery, Failed Back Syndrome, Degenerative Disk Disease and Other Applications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories (St. Jude Medical, Inc.), Neurosigma, Inc., Nevro Corporation, Synapse BioMedical, Inc., Integer Holdings Corporation, Stimwave Technologies, Inc., Nuvectra Corporation and Saluda Medical Pty Ltd.

Scope of the Study

Market Segmentation:

By Product

• Rechargeable

• Non-Rechargeable

By Application

• Complex Regional Pain Syndrome

• Unsuccessful Disk Surgery

• Failed Back Syndrome

• Degenerative Disk Disease

• Other Applications

By Country

• Germany

• UK

• France

• Russia

• Spain

• Italy

• Rest of Europe

Companies Profiled

• Boston Scientific Corporation

• Medtronic PLC

• Abbott Laboratories (St. Jude Medical, Inc.)

• Neurosigma, Inc.

• Nevro Corporation

• Synapse BioMedical, Inc.

• Integer Holdings Corporation

• Stimwave Technologies, Inc.

• Nuvectra Corporation

• Saluda Medical Pty Ltd.

Unique Offerings from KBV Research

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free